Apyx Medical (APYX) Competitors $0.99 -0.17 (-14.66%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$1.00 +0.01 (+1.21%) As of 04/4/2025 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APYX vs. ELMD, LAKE, INGN, BWAY, DRTS, PROF, TLSI, SKIN, LNSR, and OBIOShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include Electromed (ELMD), Lakeland Industries (LAKE), Inogen (INGN), BrainsWay (BWAY), Alpha Tau Medical (DRTS), Profound Medical (PROF), TriSalus Life Sciences (TLSI), Beauty Health (SKIN), LENSAR (LNSR), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Electromed Lakeland Industries Inogen BrainsWay Alpha Tau Medical Profound Medical TriSalus Life Sciences Beauty Health LENSAR Orchestra BioMed Electromed (NYSE:ELMD) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, community ranking, media sentiment and analyst recommendations. Do analysts recommend ELMD or APYX? Electromed currently has a consensus target price of $38.00, indicating a potential upside of 69.72%. Given Electromed's stronger consensus rating and higher possible upside, research analysts clearly believe Electromed is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Does the media refer more to ELMD or APYX? In the previous week, Electromed had 1 more articles in the media than Apyx Medical. MarketBeat recorded 1 mentions for Electromed and 0 mentions for Apyx Medical. Electromed's average media sentiment score of 0.72 beat Apyx Medical's score of 0.00 indicating that Electromed is being referred to more favorably in the media. Company Overall Sentiment Electromed Positive Apyx Medical Neutral Does the MarketBeat Community favor ELMD or APYX? Apyx Medical received 56 more outperform votes than Electromed when rated by MarketBeat users. However, 91.67% of users gave Electromed an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformElectromedOutperform Votes2291.67% Underperform Votes28.33%Apyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Is ELMD or APYX more profitable? Electromed has a net margin of 11.34% compared to Apyx Medical's net margin of -58.59%. Electromed's return on equity of 15.71% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Electromed11.34% 15.71% 13.37% Apyx Medical -58.59%-137.98%-36.74% Do institutionals and insiders believe in ELMD or APYX? 40.8% of Electromed shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 14.0% of Electromed shares are owned by company insiders. Comparatively, 16.8% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has better earnings & valuation, ELMD or APYX? Electromed has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElectromed$59.63M3.21$5.15M$0.7529.85Apyx Medical$48.10M0.78-$18.71M-$0.67-1.48 Which has more risk & volatility, ELMD or APYX? Electromed has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500. SummaryElectromed beats Apyx Medical on 13 of the 17 factors compared between the two stocks. Remove Ads Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.42M$3.99B$5.24B$7.07BDividend YieldN/A37.84%4.87%4.05%P/E Ratio-1.1927.4321.2017.47Price / Sales0.7846.24356.3585.24Price / CashN/A51.0838.1634.64Price / Book1.275.696.233.79Net Income-$18.71M$67.64M$3.20B$247.10M7 Day Performance-23.85%-8.67%-8.32%-7.32%1 Month Performance-16.81%-8.39%-3.36%-10.20%1 Year Performance-35.29%5.18%2.72%-7.41% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical1.7542 of 5 stars$0.99-14.7%N/A-35.3%$43.84M$48.10M-1.19270Gap DownHigh Trading VolumeELMDElectromed0.9071 of 5 stars$23.86+2.2%$38.00+59.3%+44.2%$204.17M$59.63M31.81160Gap DownLAKELakeland Industries4.5827 of 5 stars$20.31+0.2%$28.25+39.1%-3.3%$192.93M$151.82M-225.671,800Upcoming EarningsGap DownINGNInogen2.6005 of 5 stars$7.13+4.9%$7.00-1.8%+5.9%$189.16M$335.71M-3.171,030BWAYBrainsWay2.8982 of 5 stars$9.47+1.8%$13.17+39.0%+65.1%$178.29M$41.02M94.71120Gap DownDRTSAlpha Tau Medical1.9308 of 5 stars$2.51-2.0%$8.00+218.7%-13.1%$176.66MN/A-5.8480PROFProfound Medical1.9732 of 5 stars$5.82-3.8%$14.25+144.8%-39.1%$174.83M$10.68M-4.34150TLSITriSalus Life Sciences3.3078 of 5 stars$5.52-1.8%$11.56+109.5%-46.7%$171.37M$29.43M-2.22106SKINBeauty Health1.7562 of 5 stars$1.34+1.5%$2.50+86.6%-68.7%$167.83M$334.29M-3.191,030Gap UpLNSRLENSAR0.5704 of 5 stars$14.12-0.1%$15.00+6.2%+322.3%$166.46M$53.49M-9.67110High Trading VolumeOBIOOrchestra BioMed1.3819 of 5 stars$4.28-2.7%$15.40+259.8%-44.5%$162.70M$2.65M-2.664Earnings ReportAnalyst ForecastNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies ELMD Competitors LAKE Competitors INGN Competitors BWAY Competitors DRTS Competitors PROF Competitors TLSI Competitors SKIN Competitors LNSR Competitors OBIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APYX) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APYX Stock Free APYX Stock Alerts